The researchers looked at three years of medical records of more than 1 million patients with Type 2 diabetes ages 60 and up who had just started on one of the drugs
Researchers are investigating if popular drugs used for diabetes and weightloss may help prevent cognitive decline and dementia
GLP-1 agonists and tirzepatide achieve 1522% weight loss in clinical trials DSMES (Diabetes Self-Management Education and Support): ADA 2026 Recommendation 5.2 provide DSMES at diagnosis, annually, when complications develop, and at life transitions
Exp Cell Res 360:281291 [DOI] [PubMed] [Google Scholar] 48.Wu X, Li S, Xue P, Li Y (2018) Liraglutide inhibits the apoptosis of MC3T3-E1 cells induced by serum deprivation through cAMP/PKA/beta-catenin and PI3K/AKT/GSK3beta signaling pathways
More dilute solutions offer finer dose adjustments but require larger injection volumes
Anyone with a previous retina laser, injections, or vitrectomy Anyone told they have bleeding, swelling, or retinopathy Anyone with recent blurred vision, floaters, or distortion Anyone whose diabetes doctor expects a major glucose improvement over a short time Warning Signs to Watch For Starting a GLP-1 drug does not mean you should become fearful of every eye sensation
